Status:
RECRUITING
3D Contrast Enhanced Acoustic Perfusion Imaging in Adult After Subarachnoid Hemorrhage
Lead Sponsor:
University Hospital, Caen
Collaborating Sponsors:
European Research Council
Conditions:
Subarachnoid Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of stroke, with three major complications : early brain injury (EBI), vasospasm and delayed cerebral ischemia (DCI). Those patients are o...
Detailed Description
Introduction: Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of hemorrhagic stroke. Majors complications of aneurysmal SAH include early brain injury (EBI), vasospam and delayed cerebr...
Eligibility Criteria
Inclusion Criteria:
- Admitted in neurologic ICU of the CHU Caen, Normandy, for a subarachnoid hemorrhage of the anterior circulation.
- Usable ultrasound temporal window.
- 18 years old and more.
- Consent of the participant or the trusted person.
Exclusion Criteria:
- non-aneurysmal subarachnoid haemorrhage.
- Contraindication to ultrasound contrast agent Sonovue, including allergies to a compound.
- Uncontrolled systemic hypertension.
- Acute respiratory distress syndrome.
- Pregnancy or breastfeeding mother.
- Vulnerable person with guardianship or curatorship.
- Patient not affiliated to french social security system (Sécurité Sociale)
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06793839
Start Date
May 1 2024
End Date
March 1 2025
Last Update
January 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CAEN University Hospital
Caen, France, 14000